Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/14873
Tipo
ArtículoDerechos de autor
Acceso restringido
Fecha del embargo
2030-01-01
Objetivos de Desarrollo Sostenible
03 Saúde e Bem-EstarColecciones
- INI - Artigos de Periódicos [3488]
- IOC - Artigos de Periódicos [12747]
Metadatos
Mostrar el registro completo del ítem
PRETREATMENT HIV DRUG RESISTANCE AND HIV-1 SUBTYPE C ARE INDEPENDENTLY ASSOCIATED WITH VIROLOGIC FAILURE: RESULTS FROM THE MULTINATIONAL PEARLS (ACTG A5175) CLINICAL TRIAL
Autor
Kantor, Rami
Smeaton, Laura
Vardhanabhuti, Saran
Hudelson, Sarah E.
Wallis, Carol L.
Tripathy, Srikanth
Morgado, Mariza G.
Saravanan, Shanmugham
Balakrishnan, Pachamuthu
Reitsma, Marissa
Hart, Stephen
Mellors, John W.
Halvas, Elias
Grinsztejn, Beatriz
Hosseinipour, Mina C.
Kumwenda, Johnstone
La Rosa, Alberto
Lalloo, Umesh G.
Lama, Javier R.
Rassool, Mohammed
Santos, Breno R.
Supparatpinyo, Khuanchai
Hakim, James
Flanigan, Timothy
Kumarasamy, Nagalingeswaran
Campbell, Thomas B.
Eshleman, Susan H.
Smeaton, Laura
Vardhanabhuti, Saran
Hudelson, Sarah E.
Wallis, Carol L.
Tripathy, Srikanth
Morgado, Mariza G.
Saravanan, Shanmugham
Balakrishnan, Pachamuthu
Reitsma, Marissa
Hart, Stephen
Mellors, John W.
Halvas, Elias
Grinsztejn, Beatriz
Hosseinipour, Mina C.
Kumwenda, Johnstone
La Rosa, Alberto
Lalloo, Umesh G.
Lama, Javier R.
Rassool, Mohammed
Santos, Breno R.
Supparatpinyo, Khuanchai
Hakim, James
Flanigan, Timothy
Kumarasamy, Nagalingeswaran
Campbell, Thomas B.
Eshleman, Susan H.
Afiliación
Brown University. Department of Medicine. Division of Infectious Diseases. Providence, Rhode Island, USA.
Harvard University, Boston. Harvard School of Public Health. Center for Biostatistics in AIDS Research. Boston, Massachusetts, USA.
Harvard University, Boston. Harvard School of Public Health. Center for Biostatistics in AIDS Research. Boston, Massachusetts, USA.
Johns Hopkins University School of Medicine. Department of Pathology. Baltimore, Maryland, USA.
Lancet Laboratories. Johannesburg, South Africa.
National AIDS Research Institute. Pune, India.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
YRG-CARE. Chennai, India.
YRG-CARE. Chennai, India.
Brown University. Department of Medicine. Division of Infectious Diseases. Providence, Rhode Island, USA.
Frontier Science and Technology Research Foundatio. Amherst, New York, USA.
University of Pittsburgh. Department of Medicine. Division of Infectious Diseases. Pittsburgh, Pennsylvania, USA.
University of Pittsburgh. Department of Medicine. Division of Infectious Diseases. Pittsburgh, Pennsylvania, USA.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clinica Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of North Carolina Project–Malawi. Lilongwe. North Carolina, USA.
University of Malawi. College of Medicine. Department of Internal Medicine. Blantyre, Malawi.
Asociacion Civil Impacta Salud y Educacion. Barranco, Lima, Peru.
Enhancing Care Foundation. Durban, South Africa.
Asociacion Civil Impacta Salud y Educacion. Barranco, Lima, Peru.
University of Witwatersrand. Helen Joseph Hospital. Department of Medicine. Themba Lethu Clinic. Johannesburg, South Africa.
Hospital Nossa Senhora da Conceição. Serviço de Infectologia. Porto Alegre, RS, Brasil.
Chiang Mai University. Faculty of Medicine. Research Institute for Health Sciences. Thailand.
University of Zimbabwe. Department of Medicine. Harare, Zimbabwe.
Brown University. Department of Medicine. Division of Infectious Diseases. Providence, Rhode Island, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
University of Colorado Denver. Department of Medicine. Division of Infectious Diseases. Aurora, USA.
Johns Hopkins University School of Medicine. Department of Pathology. Baltimore, Maryland, USA.
Harvard University, Boston. Harvard School of Public Health. Center for Biostatistics in AIDS Research. Boston, Massachusetts, USA.
Harvard University, Boston. Harvard School of Public Health. Center for Biostatistics in AIDS Research. Boston, Massachusetts, USA.
Johns Hopkins University School of Medicine. Department of Pathology. Baltimore, Maryland, USA.
Lancet Laboratories. Johannesburg, South Africa.
National AIDS Research Institute. Pune, India.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
YRG-CARE. Chennai, India.
YRG-CARE. Chennai, India.
Brown University. Department of Medicine. Division of Infectious Diseases. Providence, Rhode Island, USA.
Frontier Science and Technology Research Foundatio. Amherst, New York, USA.
University of Pittsburgh. Department of Medicine. Division of Infectious Diseases. Pittsburgh, Pennsylvania, USA.
University of Pittsburgh. Department of Medicine. Division of Infectious Diseases. Pittsburgh, Pennsylvania, USA.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clinica Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of North Carolina Project–Malawi. Lilongwe. North Carolina, USA.
University of Malawi. College of Medicine. Department of Internal Medicine. Blantyre, Malawi.
Asociacion Civil Impacta Salud y Educacion. Barranco, Lima, Peru.
Enhancing Care Foundation. Durban, South Africa.
Asociacion Civil Impacta Salud y Educacion. Barranco, Lima, Peru.
University of Witwatersrand. Helen Joseph Hospital. Department of Medicine. Themba Lethu Clinic. Johannesburg, South Africa.
Hospital Nossa Senhora da Conceição. Serviço de Infectologia. Porto Alegre, RS, Brasil.
Chiang Mai University. Faculty of Medicine. Research Institute for Health Sciences. Thailand.
University of Zimbabwe. Department of Medicine. Harare, Zimbabwe.
Brown University. Department of Medicine. Division of Infectious Diseases. Providence, Rhode Island, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
University of Colorado Denver. Department of Medicine. Division of Infectious Diseases. Aurora, USA.
Johns Hopkins University School of Medicine. Department of Pathology. Baltimore, Maryland, USA.
Resumen en ingles
Evaluation of pretreatment HIV genotyping is needed globally to guide treatment programs. We examined the association of pretreatment (baseline) drug resistance and subtype with virologic failure in a multinational, randomized clinical trial that evaluated 3 antiretroviral treatment (ART) regimens and included resource-limited setting sites.
Compartir